CytomX Therapeutics's total assets for Q1 2025 were $98.50M, a decrease of -18.28% from the previous quarter. CTMX total liabilities were $73.45M for the fiscal quarter, a -39.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.